Global Biosimilar Insulin Market Insights and Forecast to 2031

Report ID: 1228048 | Published Date: Jan 2025 | No. of Page: 93 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Biosimilar Insulin Product Introduction
    1.2 Market by Type
        1.2.1 Global Biosimilar Insulin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Biosimilar Insulin Glargine
        1.2.3 Biosimilar Insulin Lispro
        1.2.4 Other
    1.3 Market by Distribution Channel
        1.3.1 Global Biosimilar Insulin Market Size Growth Rate by Distribution Channel, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Retail Pharmacy
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Biosimilar Insulin Sales Estimates and Forecasts 2017-2028
    2.2 Global Biosimilar Insulin Revenue Estimates and Forecasts 2017-2028
    2.3 Global Biosimilar Insulin Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Biosimilar Insulin Sales by Region
        2.4.1 Global Biosimilar Insulin Sales by Region (2017-2022)
        2.4.2 Global Sales Biosimilar Insulin by Region (2023-2028)
    2.5 Global Biosimilar Insulin Revenue by Region
        2.5.1 Global Biosimilar Insulin Revenue by Region (2017-2022)
        2.5.2 Global Biosimilar Insulin Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Biosimilar Insulin Sales by Manufacturers
        3.1.1 Global Top Biosimilar Insulin Manufacturers by Sales (2017-2022)
        3.1.2 Global Biosimilar Insulin Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biosimilar Insulin in 2021
    3.2 Global Biosimilar Insulin Revenue by Manufacturers
        3.2.1 Global Biosimilar Insulin Revenue by Manufacturers (2017-2022)
        3.2.2 Global Biosimilar Insulin Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Biosimilar Insulin Revenue in 2021
    3.3 Global Biosimilar Insulin Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Biosimilar Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Biosimilar Insulin Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Biosimilar Insulin Sales by Type
        4.1.1 Global Biosimilar Insulin Historical Sales by Type (2017-2022)
        4.1.2 Global Biosimilar Insulin Forecasted Sales by Type (2023-2028)
        4.1.3 Global Biosimilar Insulin Sales Market Share by Type (2017-2028)
    4.2 Global Biosimilar Insulin Revenue by Type
        4.2.1 Global Biosimilar Insulin Historical Revenue by Type (2017-2022)
        4.2.2 Global Biosimilar Insulin Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Biosimilar Insulin Revenue Market Share by Type (2017-2028)
    4.3 Global Biosimilar Insulin Price by Type
        4.3.1 Global Biosimilar Insulin Price by Type (2017-2022)
        4.3.2 Global Biosimilar Insulin Price Forecast by Type (2023-2028)
5 Market Size by Distribution Channel
    5.1 Global Biosimilar Insulin Sales by Distribution Channel
        5.1.1 Global Biosimilar Insulin Historical Sales by Distribution Channel (2017-2022)
        5.1.2 Global Biosimilar Insulin Forecasted Sales by Distribution Channel (2023-2028)
        5.1.3 Global Biosimilar Insulin Sales Market Share by Distribution Channel (2017-2028)
    5.2 Global Biosimilar Insulin Revenue by Distribution Channel
        5.2.1 Global Biosimilar Insulin Historical Revenue by Distribution Channel (2017-2022)
        5.2.2 Global Biosimilar Insulin Forecasted Revenue by Distribution Channel (2023-2028)
        5.2.3 Global Biosimilar Insulin Revenue Market Share by Distribution Channel (2017-2028)
    5.3 Global Biosimilar Insulin Price by Distribution Channel
        5.3.1 Global Biosimilar Insulin Price by Distribution Channel (2017-2022)
        5.3.2 Global Biosimilar Insulin Price Forecast by Distribution Channel (2023-2028)
6 North America
    6.1 North America Biosimilar Insulin Market Size by Type
        6.1.1 North America Biosimilar Insulin Sales by Type (2017-2028)
        6.1.2 North America Biosimilar Insulin Revenue by Type (2017-2028)
    6.2 North America Biosimilar Insulin Market Size by Distribution Channel
        6.2.1 North America Biosimilar Insulin Sales by Distribution Channel (2017-2028)
        6.2.2 North America Biosimilar Insulin Revenue by Distribution Channel (2017-2028)
    6.3 North America Biosimilar Insulin Market Size by Country
        6.3.1 North America Biosimilar Insulin Sales by Country (2017-2028)
        6.3.2 North America Biosimilar Insulin Revenue by Country (2017-2028)
        6.3.3 United States
        6.3.4 Canada
7 Europe
    7.1 Europe Biosimilar Insulin Market Size by Type
        7.1.1 Europe Biosimilar Insulin Sales by Type (2017-2028)
        7.1.2 Europe Biosimilar Insulin Revenue by Type (2017-2028)
    7.2 Europe Biosimilar Insulin Market Size by Distribution Channel
        7.2.1 Europe Biosimilar Insulin Sales by Distribution Channel (2017-2028)
        7.2.2 Europe Biosimilar Insulin Revenue by Distribution Channel (2017-2028)
    7.3 Europe Biosimilar Insulin Market Size by Country
        7.3.1 Europe Biosimilar Insulin Sales by Country (2017-2028)
        7.3.2 Europe Biosimilar Insulin Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Biosimilar Insulin Market Size by Type
        8.1.1 Asia Pacific Biosimilar Insulin Sales by Type (2017-2028)
        8.1.2 Asia Pacific Biosimilar Insulin Revenue by Type (2017-2028)
    8.2 Asia Pacific Biosimilar Insulin Market Size by Distribution Channel
        8.2.1 Asia Pacific Biosimilar Insulin Sales by Distribution Channel (2017-2028)
        8.2.2 Asia Pacific Biosimilar Insulin Revenue by Distribution Channel (2017-2028)
    8.3 Asia Pacific Biosimilar Insulin Market Size by Region
        8.3.1 Asia Pacific Biosimilar Insulin Sales by Region (2017-2028)
        8.3.2 Asia Pacific Biosimilar Insulin Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Biosimilar Insulin Market Size by Type
        9.1.1 Latin America Biosimilar Insulin Sales by Type (2017-2028)
        9.1.2 Latin America Biosimilar Insulin Revenue by Type (2017-2028)
    9.2 Latin America Biosimilar Insulin Market Size by Distribution Channel
        9.2.1 Latin America Biosimilar Insulin Sales by Distribution Channel (2017-2028)
        9.2.2 Latin America Biosimilar Insulin Revenue by Distribution Channel (2017-2028)
    9.3 Latin America Biosimilar Insulin Market Size by Country
        9.3.1 Latin America Biosimilar Insulin Sales by Country (2017-2028)
        9.3.2 Latin America Biosimilar Insulin Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Biosimilar Insulin Market Size by Type
        10.1.1 Middle East and Africa Biosimilar Insulin Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Biosimilar Insulin Revenue by Type (2017-2028)
    10.2 Middle East and Africa Biosimilar Insulin Market Size by Distribution Channel
        10.2.1 Middle East and Africa Biosimilar Insulin Sales by Distribution Channel (2017-2028)
        10.2.2 Middle East and Africa Biosimilar Insulin Revenue by Distribution Channel (2017-2028)
    10.3 Middle East and Africa Biosimilar Insulin Market Size by Country
        10.3.1 Middle East and Africa Biosimilar Insulin Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Biosimilar Insulin Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Eli Lilly
        11.1.1 Eli Lilly Corporation Information
        11.1.2 Eli Lilly Overview
        11.1.3 Eli Lilly Biosimilar Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Eli Lilly Biosimilar Insulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Eli Lilly Recent Developments
    11.2 Sanofi
        11.2.1 Sanofi Corporation Information
        11.2.2 Sanofi Overview
        11.2.3 Sanofi Biosimilar Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Sanofi Biosimilar Insulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Sanofi Recent Developments
    11.3 Gan&Lee
        11.3.1 Gan&Lee Corporation Information
        11.3.2 Gan&Lee Overview
        11.3.3 Gan&Lee Biosimilar Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Gan&Lee Biosimilar Insulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Gan&Lee Recent Developments
    11.4 Tonghua Dongbao
        11.4.1 Tonghua Dongbao Corporation Information
        11.4.2 Tonghua Dongbao Overview
        11.4.3 Tonghua Dongbao Biosimilar Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Tonghua Dongbao Biosimilar Insulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Tonghua Dongbao Recent Developments
    11.5 United Laboratory
        11.5.1 United Laboratory Corporation Information
        11.5.2 United Laboratory Overview
        11.5.3 United Laboratory Biosimilar Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 United Laboratory Biosimilar Insulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 United Laboratory Recent Developments
    11.6 Geropharm
        11.6.1 Geropharm Corporation Information
        11.6.2 Geropharm Overview
        11.6.3 Geropharm Biosimilar Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Geropharm Biosimilar Insulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Geropharm Recent Developments
    11.7 Biocon
        11.7.1 Biocon Corporation Information
        11.7.2 Biocon Overview
        11.7.3 Biocon Biosimilar Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Biocon Biosimilar Insulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Biocon Recent Developments
    11.8 Wockhardt
        11.8.1 Wockhardt Corporation Information
        11.8.2 Wockhardt Overview
        11.8.3 Wockhardt Biosimilar Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Wockhardt Biosimilar Insulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Wockhardt Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Biosimilar Insulin Industry Chain Analysis
    12.2 Biosimilar Insulin Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Biosimilar Insulin Production Mode & Process
    12.4 Biosimilar Insulin Sales and Marketing
        12.4.1 Biosimilar Insulin Sales Channels
        12.4.2 Biosimilar Insulin Distributors
    12.5 Biosimilar Insulin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Biosimilar Insulin Industry Trends
    13.2 Biosimilar Insulin Market Drivers
    13.3 Biosimilar Insulin Market Challenges
    13.4 Biosimilar Insulin Market Restraints
14 Key Findings in The Global Biosimilar Insulin Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Biosimilar Insulin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Biosimilar Insulin Glargine
    Table 3. Major Manufacturers of Biosimilar Insulin Lispro
    Table 4. Major Manufacturers of Other
    Table 5. Global Biosimilar Insulin Market Size Growth Rate by Distribution Channel, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Biosimilar Insulin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Biosimilar Insulin Sales by Region (2017-2022) & (K Unit)
    Table 8. Global Biosimilar Insulin Sales Market Share by Region (2017-2022)
    Table 9. Global Biosimilar Insulin Sales by Region (2023-2028) & (K Unit)
    Table 10. Global Biosimilar Insulin Sales Market Share by Region (2023-2028)
    Table 11. Global Biosimilar Insulin Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Biosimilar Insulin Revenue Market Share by Region (2017-2022)
    Table 13. Global Biosimilar Insulin Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Biosimilar Insulin Revenue Market Share by Region (2023-2028)
    Table 15. Global Biosimilar Insulin Sales by Manufacturers (2017-2022) & (K Unit)
    Table 16. Global Biosimilar Insulin Sales Share by Manufacturers (2017-2022)
    Table 17. Global Biosimilar Insulin Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Biosimilar Insulin Revenue Share by Manufacturers (2017-2022)
    Table 19. Biosimilar Insulin Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 20. Global Biosimilar Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Biosimilar Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Insulin as of 2021)
    Table 22. Biosimilar Insulin Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Biosimilar Insulin Product Offered
    Table 24. Date of Manufacturers Enter into Biosimilar Insulin Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Biosimilar Insulin Sales by Type (2017-2022) & (K Unit)
    Table 27. Global Biosimilar Insulin Sales by Type (2023-2028) & (K Unit)
    Table 28. Global Biosimilar Insulin Sales Share by Type (2017-2022)
    Table 29. Global Biosimilar Insulin Sales Share by Type (2023-2028)
    Table 30. Global Biosimilar Insulin Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Biosimilar Insulin Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Biosimilar Insulin Revenue Share by Type (2017-2022)
    Table 33. Global Biosimilar Insulin Revenue Share by Type (2023-2028)
    Table 34. Biosimilar Insulin Price by Type (2017-2022) & (US$/Unit)
    Table 35. Global Biosimilar Insulin Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 36. Global Biosimilar Insulin Sales by Distribution Channel (2017-2022) & (K Unit)
    Table 37. Global Biosimilar Insulin Sales by Distribution Channel (2023-2028) & (K Unit)
    Table 38. Global Biosimilar Insulin Sales Share by Distribution Channel (2017-2022)
    Table 39. Global Biosimilar Insulin Sales Share by Distribution Channel (2023-2028)
    Table 40. Global Biosimilar Insulin Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 41. Global Biosimilar Insulin Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 42. Global Biosimilar Insulin Revenue Share by Distribution Channel (2017-2022)
    Table 43. Global Biosimilar Insulin Revenue Share by Distribution Channel (2023-2028)
    Table 44. Biosimilar Insulin Price by Distribution Channel (2017-2022) & (US$/Unit)
    Table 45. Global Biosimilar Insulin Price Forecast by Distribution Channel (2023-2028) & (US$/Unit)
    Table 46. North America Biosimilar Insulin Sales by Type (2017-2022) & (K Unit)
    Table 47. North America Biosimilar Insulin Sales by Type (2023-2028) & (K Unit)
    Table 48. North America Biosimilar Insulin Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Biosimilar Insulin Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Biosimilar Insulin Sales by Distribution Channel (2017-2022) & (K Unit)
    Table 51. North America Biosimilar Insulin Sales by Distribution Channel (2023-2028) & (K Unit)
    Table 52. North America Biosimilar Insulin Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 53. North America Biosimilar Insulin Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 54. North America Biosimilar Insulin Sales by Country (2017-2022) & (K Unit)
    Table 55. North America Biosimilar Insulin Sales by Country (2023-2028) & (K Unit)
    Table 56. North America Biosimilar Insulin Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Biosimilar Insulin Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Biosimilar Insulin Sales by Type (2017-2022) & (K Unit)
    Table 59. Europe Biosimilar Insulin Sales by Type (2023-2028) & (K Unit)
    Table 60. Europe Biosimilar Insulin Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Biosimilar Insulin Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Biosimilar Insulin Sales by Distribution Channel (2017-2022) & (K Unit)
    Table 63. Europe Biosimilar Insulin Sales by Distribution Channel (2023-2028) & (K Unit)
    Table 64. Europe Biosimilar Insulin Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 65. Europe Biosimilar Insulin Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 66. Europe Biosimilar Insulin Sales by Country (2017-2022) & (K Unit)
    Table 67. Europe Biosimilar Insulin Sales by Country (2023-2028) & (K Unit)
    Table 68. Europe Biosimilar Insulin Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Biosimilar Insulin Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Biosimilar Insulin Sales by Type (2017-2022) & (K Unit)
    Table 71. Asia Pacific Biosimilar Insulin Sales by Type (2023-2028) & (K Unit)
    Table 72. Asia Pacific Biosimilar Insulin Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Biosimilar Insulin Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Biosimilar Insulin Sales by Distribution Channel (2017-2022) & (K Unit)
    Table 75. Asia Pacific Biosimilar Insulin Sales by Distribution Channel (2023-2028) & (K Unit)
    Table 76. Asia Pacific Biosimilar Insulin Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Biosimilar Insulin Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Biosimilar Insulin Sales by Region (2017-2022) & (K Unit)
    Table 79. Asia Pacific Biosimilar Insulin Sales by Region (2023-2028) & (K Unit)
    Table 80. Asia Pacific Biosimilar Insulin Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Biosimilar Insulin Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Biosimilar Insulin Sales by Type (2017-2022) & (K Unit)
    Table 83. Latin America Biosimilar Insulin Sales by Type (2023-2028) & (K Unit)
    Table 84. Latin America Biosimilar Insulin Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Biosimilar Insulin Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Biosimilar Insulin Sales by Distribution Channel (2017-2022) & (K Unit)
    Table 87. Latin America Biosimilar Insulin Sales by Distribution Channel (2023-2028) & (K Unit)
    Table 88. Latin America Biosimilar Insulin Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 89. Latin America Biosimilar Insulin Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 90. Latin America Biosimilar Insulin Sales by Country (2017-2022) & (K Unit)
    Table 91. Latin America Biosimilar Insulin Sales by Country (2023-2028) & (K Unit)
    Table 92. Latin America Biosimilar Insulin Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Biosimilar Insulin Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Biosimilar Insulin Sales by Type (2017-2022) & (K Unit)
    Table 95. Middle East and Africa Biosimilar Insulin Sales by Type (2023-2028) & (K Unit)
    Table 96. Middle East and Africa Biosimilar Insulin Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Biosimilar Insulin Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Biosimilar Insulin Sales by Distribution Channel (2017-2022) & (K Unit)
    Table 99. Middle East and Africa Biosimilar Insulin Sales by Distribution Channel (2023-2028) & (K Unit)
    Table 100. Middle East and Africa Biosimilar Insulin Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Biosimilar Insulin Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Biosimilar Insulin Sales by Country (2017-2022) & (K Unit)
    Table 103. Middle East and Africa Biosimilar Insulin Sales by Country (2023-2028) & (K Unit)
    Table 104. Middle East and Africa Biosimilar Insulin Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Biosimilar Insulin Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Eli Lilly Corporation Information
    Table 107. Eli Lilly Description and Major Businesses
    Table 108. Eli Lilly Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 109. Eli Lilly Biosimilar Insulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Eli Lilly Recent Developments
    Table 111. Sanofi Corporation Information
    Table 112. Sanofi Description and Major Businesses
    Table 113. Sanofi Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 114. Sanofi Biosimilar Insulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Sanofi Recent Developments
    Table 116. Gan&Lee Corporation Information
    Table 117. Gan&Lee Description and Major Businesses
    Table 118. Gan&Lee Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 119. Gan&Lee Biosimilar Insulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Gan&Lee Recent Developments
    Table 121. Tonghua Dongbao Corporation Information
    Table 122. Tonghua Dongbao Description and Major Businesses
    Table 123. Tonghua Dongbao Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 124. Tonghua Dongbao Biosimilar Insulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Tonghua Dongbao Recent Developments
    Table 126. United Laboratory Corporation Information
    Table 127. United Laboratory Description and Major Businesses
    Table 128. United Laboratory Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 129. United Laboratory Biosimilar Insulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. United Laboratory Recent Developments
    Table 131. Geropharm Corporation Information
    Table 132. Geropharm Description and Major Businesses
    Table 133. Geropharm Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 134. Geropharm Biosimilar Insulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Geropharm Recent Developments
    Table 136. Biocon Corporation Information
    Table 137. Biocon Description and Major Businesses
    Table 138. Biocon Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 139. Biocon Biosimilar Insulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Biocon Recent Developments
    Table 141. Wockhardt Corporation Information
    Table 142. Wockhardt Description and Major Businesses
    Table 143. Wockhardt Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 144. Wockhardt Biosimilar Insulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Wockhardt Recent Developments
    Table 146. Key Raw Materials Lists
    Table 147. Raw Materials Key Suppliers Lists
    Table 148. Biosimilar Insulin Distributors List
    Table 149. Biosimilar Insulin Customers List
    Table 150. Biosimilar Insulin Market Trends
    Table 151. Biosimilar Insulin Market Drivers
    Table 152. Biosimilar Insulin Market Challenges
    Table 153. Biosimilar Insulin Market Restraints
    Table 154. Research Programs/Design for This Report
    Table 155. Key Data Information from Secondary Sources
    Table 156. Key Data Information from Primary Sources
List of Figures
    Figure 1. Biosimilar Insulin Product Picture
    Figure 3. Global Biosimilar Insulin Market Share by Type in 2021 & 2028
    Figure 3. Biosimilar Insulin Glargine Product Picture
    Figure 4. Biosimilar Insulin Lispro Product Picture
    Figure 5. Other Product Picture
    Figure 6. Global Biosimilar Insulin Market Share by Distribution Channel in 2021 & 2028
    Figure 7. Hospital
    Figure 8. Retail Pharmacy
    Figure 9. Others
    Figure 10. Biosimilar Insulin Report Years Considered
    Figure 11. Global Biosimilar Insulin Sales 2017-2028 (K Unit)
    Figure 12. Global Biosimilar Insulin Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Biosimilar Insulin Revenue 2017-2028 (US$ Million)
    Figure 14. Global Biosimilar Insulin Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Biosimilar Insulin Sales Market Share by Region (2017-2022)
    Figure 16. Global Biosimilar Insulin Sales Market Share by Region (2023-2028)
    Figure 17. North America Biosimilar Insulin Sales YoY (2017-2028) & (K Unit)
    Figure 18. North America Biosimilar Insulin Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Biosimilar Insulin Sales YoY (2017-2028) & (K Unit)
    Figure 20. Europe Biosimilar Insulin Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Biosimilar Insulin Sales YoY (2017-2028) & (K Unit)
    Figure 22. Asia-Pacific Biosimilar Insulin Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Biosimilar Insulin Sales YoY (2017-2028) & (K Unit)
    Figure 24. Latin America Biosimilar Insulin Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Biosimilar Insulin Sales YoY (2017-2028) & (K Unit)
    Figure 26. Middle East & Africa Biosimilar Insulin Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Biosimilar Insulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Biosimilar Insulin in the World: Market Share by Biosimilar Insulin Revenue in 2021
    Figure 29. Global Biosimilar Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Biosimilar Insulin Sales Market Share by Type (2017-2028)
    Figure 31. Global Biosimilar Insulin Revenue Market Share by Type (2017-2028)
    Figure 32. Global Biosimilar Insulin Sales Market Share by Distribution Channel (2017-2028)
    Figure 33. Global Biosimilar Insulin Revenue Market Share by Distribution Channel (2017-2028)
    Figure 34. North America Biosimilar Insulin Sales Market Share by Type (2017-2028)
    Figure 35. North America Biosimilar Insulin Revenue Market Share by Type (2017-2028)
    Figure 36. North America Biosimilar Insulin Sales Market Share by Distribution Channel (2017-2028)
    Figure 37. North America Biosimilar Insulin Revenue Market Share by Distribution Channel (2017-2028)
    Figure 38. North America Biosimilar Insulin Sales Share by Country (2017-2028)
    Figure 39. North America Biosimilar Insulin Revenue Share by Country (2017-2028)
    Figure 40. United States Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Biosimilar Insulin Sales Market Share by Type (2017-2028)
    Figure 43. Europe Biosimilar Insulin Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Biosimilar Insulin Sales Market Share by Distribution Channel (2017-2028)
    Figure 45. Europe Biosimilar Insulin Revenue Market Share by Distribution Channel (2017-2028)
    Figure 46. Europe Biosimilar Insulin Sales Share by Country (2017-2028)
    Figure 47. Europe Biosimilar Insulin Revenue Share by Country (2017-2028)
    Figure 48. Germany Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 49. France Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Biosimilar Insulin Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Biosimilar Insulin Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Biosimilar Insulin Sales Market Share by Distribution Channel (2017-2028)
    Figure 56. Asia Pacific Biosimilar Insulin Revenue Market Share by Distribution Channel (2017-2028)
    Figure 57. Asia Pacific Biosimilar Insulin Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Biosimilar Insulin Revenue Share by Region (2017-2028)
    Figure 59. China Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 62. India Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 64. China Taiwan Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Biosimilar Insulin Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Biosimilar Insulin Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Biosimilar Insulin Sales Market Share by Distribution Channel (2017-2028)
    Figure 71. Latin America Biosimilar Insulin Revenue Market Share by Distribution Channel (2017-2028)
    Figure 72. Latin America Biosimilar Insulin Sales Share by Country (2017-2028)
    Figure 73. Latin America Biosimilar Insulin Revenue Share by Country (2017-2028)
    Figure 74. Mexico Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Biosimilar Insulin Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Biosimilar Insulin Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Biosimilar Insulin Sales Market Share by Distribution Channel (2017-2028)
    Figure 80. Middle East and Africa Biosimilar Insulin Revenue Market Share by Distribution Channel (2017-2028)
    Figure 81. Middle East and Africa Biosimilar Insulin Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Biosimilar Insulin Revenue Share by Country (2017-2028)
    Figure 83. Turkey Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 85. UAE Biosimilar Insulin Revenue (2017-2028) & (US$ Million)
    Figure 86. Biosimilar Insulin Value Chain
    Figure 87. Biosimilar Insulin Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly
Sanofi
Gan&Lee
Tonghua Dongbao
United Laboratory
Geropharm
Biocon
Wockhardt
Frequently Asked Questions
Biosimilar Insulin report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biosimilar Insulin report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biosimilar Insulin report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Gasification

Gasification market is segmented by players, region (country), by Type and by Application. Player ... Read More